Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹1600.00 Cr |
| Fresh Issue | ₹1000.31 Cr |
| Offer for Sale | ₹599.69 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹1195.00-1258.00 per share |
| Discount | Retail: 0.00,Employee: 119.00 |
| BSE Code | 544122 |
| NSE Code | ENTERO |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | ICICI Securities Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 11 shares and in multiples thereof
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.
Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.
The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a total of 3014 people in various departments.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/prepayment, in full or part, of certain borrowings availed of by our Company | 142.50 |
| 2 | Funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026 | 480.00 |
| 3 | General corporate purposes | 91.70 |
| 4 | Pursuing inorganic growth initiatives through acquisitions | 237.00 |
| Total | 951.20 |
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 1,505.95 | 1,308.73 | 1,125.98 | 833.79 |
| Total Income | 1,898.98 | 3,305.72 | 2,526.55 | 1,783.67 |
| Profit After Tax | 11.64 | -11.10 | -29.44 | -15.35 |
| NET Worth | 660.54 | 597.66 | 563.22 | 487.06 |
| Total Borrowing | 488.68 | 373.52 | 285.03 | 141.70 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | -2.66% |
| ROCE | 6.06% |
| Debt / Equity | 0.45% |
| RoNW | -1.86% |
| PAT Margin | 4.69% |
| Price to Book Value | 7.22 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 0.00 | 9.70 |
| P/E (x) | 0 | 129.75 |
| Promoter Holding | 77.11% | 52.43% |
| Market Cap | ₹3021.21 Cr. | |
